Moreover, treating MARV-infected bat alvORG with the JAK–STAT signaling inhibitor ruxolitinib during infection significantly increased intracellular viral RNA (Fig. 8i), indicating that endogenous IFN signaling was required to limit MARV replication. This evidence concerns the gene IFNA1 and infection.